Statements of Consolidated Cash Flows (USD $) | | | |
In Millions | 12 Months Ended
Dec. 31, 2009
| 12 Months Ended
Dec. 31, 2008
| 12 Months Ended
Dec. 31, 2007
|
Operating activities: | | | |
Net income (loss) | $2,093 | $1,160 | ($1,485) |
Adjustments: | | | |
Amortization | 806 | 738 | 685 |
Stock based compensation and other benefits | 57 | 50 | 46 |
Accretion of accumulated reclamation obligations (Note 25) | 46 | 41 | 35 |
Revaluation of contingent consideration (Note 13) | 23 | 0 | 0 |
Loss (income) from discontinued operations (Note 10) | 16 | (13) | 905 |
Reclamation estimate revisions (Note 25) | 13 | 101 | 29 |
Write-down of property, plant and mine development | 7 | 137 | 10 |
Impairment of marketable securities (Note 16) | 6 | 114 | 46 |
Deferred income taxes | 1 | (315) | (156) |
Write-down of goodwill | 0 | 0 | 1,122 |
Gain on asset sales, net | (24) | (72) | (10) |
Other operating adjustments and write-downs | 97 | 83 | 30 |
Net change in operating assets and liabilities (Note 28) | (227) | (627) | (729) |
Net cash provided from continuing operations | 2,914 | 1,397 | 528 |
Net cash provided from (used in) discontinued operations (Note 10) | 33 | (104) | 137 |
Net cash provided from operations | 2,947 | 1,293 | 665 |
Investing activities: | | | |
Additions to property, plant and mine development | (1,769) | (1,870) | (1,669) |
Acquisitions, net (Note 13) | (1,007) | (325) | (953) |
Sales of marketable securities | 17 | 50 | 224 |
Purchases of marketable securities | (5) | (17) | (258) |
Repayment of noncontrolling partner loan (Note 11) | 0 | 0 | 161 |
Other | (17) | 16 | 23 |
Net cash used in investing activities of continuing operations | (2,781) | (2,146) | (2,472) |
Net cash provided from (used in) investing activities of discontinued operations (Note 10) | 0 | (11) | 1,359 |
Net cash used in investing activities | (2,781) | (2,157) | (1,113) |
Financing activities: | | | |
Proceeds from debt, net | 4,299 | 5,078 | 3,001 |
Repayment of debt | (2,731) | (4,483) | (2,036) |
Proceeds from stock issuance, net | 1,278 | 29 | 51 |
Sale of subsidiary shares to noncontrolling interests (Note 11) | 638 | 0 | 0 |
Acquisition of subsidiary shares from noncontrolling interests (Note 11) | (287) | 0 | 0 |
Dividends paid to noncontrolling interests | (394) | (389) | (270) |
Dividends paid to common stockholders | (196) | (182) | (181) |
Purchase of Company share call options (Note 12) | 0 | 0 | (366) |
Issuance of Company share warrants (Note 12) | 0 | 0 | 248 |
Change in restricted cash and other | (35) | 74 | 11 |
Net cash provided from financing activities of continuing operations | 2,572 | 127 | 458 |
Net cash provided from (used in) financing activities of discontinued operations (Note 10) | (2) | (4) | 7 |
Net cash provided from financing activities | 2,570 | 123 | 465 |
Effect of exchange rate changes on cash | 44 | (54) | 50 |
Net change in cash and cash equivalents | 2,780 | (795) | 67 |
Cash and cash equivalents at beginning of period | 435 | 1,230 | 1,163 |
Cash and cash equivalents at end of period | $3,215 | $435 | $1,230 |